The World Health Organization has published its first ever guidelines on treating type 1 diabetes in adults, released on 14 November 2026 for World Diabetes Day. The headline advice: adults with type 1 diabetes should be on multiple daily insulin injections with doses adjusted to their blood sugar, and most should aim for an HbA1c of 7.0% (53 mmol/mol) or lower.
If you live with type 1 diabetes in the US, UK or another country with established diabetes services, much of this will sound familiar. The bigger story is what it means for the millions of adults worldwide who still struggle to get insulin, test strips and trained staff. Here’s what the guideline actually says, what changes, and what you can do with it.
What happened
On 14 November 2026, WHO announced its first guidelines on the diagnosis and management of type 1 diabetes in adults. The full document, Guidelines on insulin use for type 1 diabetes in adults, including in emergency and humanitarian settings, is dated 12 November 2026 and runs to 125 pages.
It’s written to work everywhere, including low-income countries, emergencies and humanitarian settings where insulin supplies and fridges can’t be taken for granted. WHO says about 9.5 million people were living with type 1 diabetes in 2025, with more than 500,000 new diagnoses that year. The guideline also points out that a large share of new cases now occur in adults rather than children.
Dr Søren Brostrøm, WHO’s Director of Noncommunicable Diseases and Mental Health, said in the release that many people with type 1 diabetes still can’t get affordable, good-quality insulin more than 100 years after it was discovered.
The 14 recommendations at a glance
The guideline contains 14 recommendations. Only one is “strong” (intensified insulin therapy). The other 13 are “conditional”, which means benefits probably outweigh harms for most people but your circumstances and preferences should shape the decision.
| Area | What WHO recommends |
|---|---|
| Diagnosis | Consider islet autoantibody tests and C-peptide when it’s unclear whether an adult has type 1 diabetes |
| Insulin regimen | Intensified insulin therapy: multiple daily injections with doses adjusted to blood glucose (strong recommendation) |
| Mealtime (bolus) insulin | Human insulin or analogues are both acceptable; human insulin preferred because it usually costs less. Ultra rapid-acting analogues can be considered |
| Background (basal) insulin | Human (NPH) insulin or analogues are both acceptable; human insulin preferred on cost. Once-daily long-acting analogues can be taken at the time of day you prefer |
| Premixed insulin | Premixed or self-mixed human insulin can be considered |
| Delivery | Consider insulin pens over syringes |
| Clinic monitoring | HbA1c testing up to every three months; target HbA1c of 7.0% (53 mmol/mol) or lower for most adults |
| Home monitoring | Fingerstick testing, real-time CGM or flash (intermittently scanned) CGM; check three or more times a day |
| When blood testing isn’t available | Urine glucose testing as a fallback, not a replacement |
What changes for you
That depends a lot on where you live.
If you’re in the US, UK, Canada or Australia
Most adults with type 1 diabetes in these countries are already on basal-bolus injections or a pump, use analogue insulins, and have access to CGM. The WHO guideline doesn’t override your national guidance. In the UK, NICE remains the reference for NHS care, and in the US your care team will still follow American Diabetes Association standards. So nothing changes overnight.
Two points are still worth knowing. First, the HbA1c target of 7.0% (53 mmol/mol) or lower gives you a clear global benchmark to discuss with your team, though your own target may be different. Second, WHO explicitly backs CGM as one of the acceptable ways to self-monitor, which can be useful if you’re making a case to an insurer or local health service.
If you’re in India or another low- or middle-income country
This is where the guideline could matter most. It tells governments and clinics that cheaper human insulin given as multiple daily injections is a sound, evidence-based choice. It pushes for pens over syringes and for regular glucose testing. And WHO links it to a target that every person with type 1 diabetes should have affordable insulin and blood glucose self-monitoring by 2030.
In practice, a health system that once offered only one or two fixed doses of mixed insulin a day now has a clear WHO document saying that’s not the preferred standard for adults.
Who is affected
- Adults with type 1 diabetes. The guideline covers adults aged 18 and over.
- Adults who might be misdiagnosed. WHO notes that type 1 diabetes in adults is often missed or labelled as type 2. That can mean someone is put on tablets when they really need insulin. The advice to use autoantibody and C-peptide tests when the type is unclear is aimed at exactly this problem.
- People in emergencies. Refugees, people in conflict zones and those hit by disasters are specifically covered, with advice adapted to broken supply chains and no reliable refrigeration.
Children and teenagers aren’t covered by this document. If your child has type 1 diabetes, their paediatric team’s guidance still applies. You can read more about early symptoms in our guide to type 1 diabetes signs in children.
What’s not in it
The guideline is deliberately focused on insulin use and monitoring. WHO says it doesn’t cover:
- insulin pumps or automated insulin delivery (“closed loop”) systems
- treating diabetic ketoacidosis (DKA) or long-term complications
- combining insulin with metformin or GLP-1 medicines
- broader diabetes education that isn’t directly about safe insulin use
So if you use a pump or closed-loop system, this guideline neither recommends for nor against it. It simply doesn’t address it.
What to do now
- Know your HbA1c. If you don’t know your last result, ask. 7.0% is the same as 53 mmol/mol. If you’re unsure how HbA1c compares with a fasting test, see our explainer on HbA1c vs fasting blood sugar.
- Check how many times a day you test. WHO suggests three or more checks a day if you use a meter. If you’re testing less because strips are expensive, raise it with your clinic.
- Ask about pens. If you still use vials and syringes, ask whether pens are available to you.
- Don’t switch insulin on your own. Moving between analogue and human insulin changes timing and dosing. Do it only with your diabetes team.
- If you were diagnosed with type 2 but need insulin early, ask about testing. Slim adults, those who lose weight fast, or people who don’t respond well to tablets can ask whether autoantibody or C-peptide testing makes sense.
When to get urgent help
The NHS warns that some symptoms can signal diabetic ketoacidosis, which can be life-threatening. Call your local emergency number (911 in the US, 999 in the UK, 112 in the EU and India) if you or someone with diabetes has:
- symptoms getting worse quickly
- stomach pain, vomiting or diarrhoea
- sleepiness or confusion
- breathing that’s faster and deeper than usual
Also get help fast for a severe low blood sugar (hypo) where the person can’t swallow safely or is unconscious. Don’t drive yourself to hospital.
If you haven’t been diagnosed but notice being very thirsty, passing urine much more, feeling exhausted and losing weight without trying, the CDC notes that type 1 symptoms can come on within weeks. See a doctor the same day.
What’s still unclear
- How fast countries adopt it. WHO guidelines aren’t law. National health ministries decide what goes into their programmes and essential medicines lists.
- Funding. The 2030 access target needs money for insulin, pens, meters and staff training. The guideline doesn’t come with funding.
- Technology. With pumps and closed-loop systems left out, there’s no WHO position yet on where they fit, especially as prices fall.
- Children. This document is adult-only, so there’s still a gap for a matching global guideline on children and teenagers.
Frequently asked questions
Is human insulin as good as newer analogue insulins?
WHO judged that either can be used for mealtime and background insulin. It prefers human insulin mainly because it’s usually cheaper. Analogues may suit people with repeated severe or night-time hypos despite good education and correct use of human insulin.
What does an HbA1c of 7% mean in mmol/mol?
7.0% is 53 mmol/mol. Labs in the UK and many other countries report mmol/mol, while the US commonly uses the percentage.
Do I need a continuous glucose monitor?
Not necessarily. WHO lists fingerstick testing, real-time CGM and flash CGM as acceptable options. The point is to monitor regularly with whatever you can reliably get.
Can urine tests replace blood glucose checks?
No. WHO only suggests urine glucose testing when blood testing isn’t available, and says it shouldn’t replace blood testing where blood testing is possible.
Does this guideline change treatment for type 2 diabetes?
No. It’s only about adults with type 1 diabetes. If you have prediabetes or type 2, our guide to prediabetes test numbers and how to reverse it is a better starting point.
This article is for general information and is not a substitute for advice from a doctor. If you have symptoms or a health condition, please consult a qualified healthcare professional.

